124 related articles for article (PubMed ID: 36811267)
1. Use of the FreeStyle Libre system and diabetes treatment progression in T2DM: Results from a retrospective cohort study using a Canadian private payer claims database.
Harris SB; Levrat-Guillen F
Diabetes Obes Metab; 2023 Jun; 25(6):1704-1713. PubMed ID: 36811267
[TBL] [Abstract][Full Text] [Related]
2. Reduced Acute Diabetes Events After FreeStyle Libre System Initiation in People 65 Years or Older with Type 2 Diabetes on Intensive Insulin Therapy in France.
Guerci B; Levrat-Guillen F; Vicaut E; De Pouvourville G; Detournay B; Emery C; Riveline JP
Diabetes Technol Ther; 2023 Jun; 25(6):384-394. PubMed ID: 36944104
[No Abstract] [Full Text] [Related]
3. Important Decrease in Hospitalizations for Acute Diabetes Events Following FreeStyle Libre System Initiation in People with Type 2 Diabetes on Basal Insulin Therapy in France.
Guerci B; Roussel R; Levrat-Guillen F; Detournay B; Vicaut E; De Pouvourville G; Emery C; Riveline JP
Diabetes Technol Ther; 2023 Jan; 25(1):20-30. PubMed ID: 36094418
[No Abstract] [Full Text] [Related]
4. Reduced Rate of Hospitalizations for Acute Diabetes Events Before and After FreeStyle Libre
Riveline JP; Levrat-Guillen F; Detournay B; Vicaut E; De Pouvourville G; Emery C; Guerci B
Diabetes Technol Ther; 2024 Jul; ():. PubMed ID: 38885325
[No Abstract] [Full Text] [Related]
5. Budget Impact Analysis of the FreeStyle Libre Flash Continuous Glucose Monitoring System
Palacios A; Rodriguez-Cairoli F; Balan D; Rojas-Roque C; Moreno-López C; Braun B; Augustovski F; Pichon-Riviere A; Bardach A
Appl Health Econ Health Policy; 2023 Jul; 21(4):637-650. PubMed ID: 37062046
[TBL] [Abstract][Full Text] [Related]
6. Real-world study of flash glucose monitoring among adults with type 2 diabetes within the Swedish National Diabetes Register.
Eeg-Olofsson K; Svensson AM; Franzén S; Ahmed Ismail H; Törnblom M; Levrat-Guillen F
Diab Vasc Dis Res; 2023; 20(1):14791641211067418. PubMed ID: 36715353
[TBL] [Abstract][Full Text] [Related]
7. Comparison of glucose monitoring between Freestyle Libre Pro and iPro2 in patients with diabetes mellitus.
Kumagai R; Muramatsu A; Fujii M; Katakura Y; Ito K; Fujie K; Nakata Y; Hashimoto K; Yagyu H
J Diabetes Investig; 2019 May; 10(3):851-856. PubMed ID: 30390385
[TBL] [Abstract][Full Text] [Related]
8. Impact of the FreeStyle Libre flash glucose monitoring system on diabetes- self-management practices and glycemic control among patients with type 2 diabetes in Saudi Arabia: A prospective study.
Al Hayek A; Robert AA; Al Dawish M
Diabetes Metab Syndr; 2021; 15(2):557-563. PubMed ID: 33689937
[TBL] [Abstract][Full Text] [Related]
9. Budget impact analysis of the freestyle libre flash continuous glucose monitoring system® in patients with diabetes mellitus type 1 in Chile.
Palacios A; Rodriguez Cairoli F; Balan D; Balmaceda C; Augustovski F; Pichon-Riviere A; Bardach A
Expert Rev Pharmacoecon Outcomes Res; 2023 Mar; 23(3):353-363. PubMed ID: 36701814
[TBL] [Abstract][Full Text] [Related]
10. Reduced Rate of Acute Diabetes Events with Flash Glucose Monitoring Is Sustained for 2 Years After Initiation: Extended Outcomes from the RELIEF Study.
Riveline JP; Roussel R; Vicaut E; de Pouvourville G; Detournay B; Emery C; Levrat-Guillen F; Guerci B
Diabetes Technol Ther; 2022 Sep; 24(9):611-618. PubMed ID: 35604792
[No Abstract] [Full Text] [Related]
11. Cost-Effectiveness of the FreeStyle Libre
Jendle J; Eeg-Olofsson K; Svensson AM; Franzen S; Lamotte M; Levrat-Guillen F
Diabetes Ther; 2021 Dec; 12(12):3137-3152. PubMed ID: 34694584
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of continuous glucose monitoring with FreeStyle Libre
Bahia L; Mello KF; Lemos LLP; Costa NL; Mulinari E; Malerbi DA
Diabetol Metab Syndr; 2023 Nov; 15(1):242. PubMed ID: 38001509
[TBL] [Abstract][Full Text] [Related]
13. Impact of factory-calibrated Freestyle Libre System with new glucose algorithm measurement accuracy and clinical performance in children with type 1 diabetes during summer camp.
Szadkowska A; Michalak A; Łosiewicz A; Kuśmierczyk H; Krawczyk-Rusiecka K; Chrzanowski J; Gawrecki A; Zozulińska-Ziółkiewicz D; Fendler W
Pediatr Diabetes; 2021 Mar; 22(2):261-270. PubMed ID: 33034075
[TBL] [Abstract][Full Text] [Related]
14. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
[TBL] [Abstract][Full Text] [Related]
15. Initiating GLP-1 Therapy in Combination with FreeStyle Libre Provides Greater Benefit Compared with GLP-1 Therapy Alone.
Wright EE; Roberts GJ; Chuang JS; Nabutovsky Y; Virdi N; Miller E
Diabetes Technol Ther; 2024 May; ():. PubMed ID: 38669474
[No Abstract] [Full Text] [Related]
16. The use of flash glucose monitoring significantly improves glycemic control in type 2 diabetes managed with basal bolus insulin therapy compared to self-monitoring of blood glucose: A prospective observational cohort study.
Bosi E; Gregori G; Cruciani C; Irace C; Pozzilli P; Buzzetti R
Diabetes Res Clin Pract; 2022 Jan; 183():109172. PubMed ID: 34883185
[TBL] [Abstract][Full Text] [Related]
17. Determinants of HbA1c reduction with FreeStyle Libre flash glucose monitoring (FLARE-NL 5).
Lameijer A; Fokkert MJ; Edens MA; Slingerland RJ; Bilo HJG; van Dijk PR
J Clin Transl Endocrinol; 2020 Dec; 22():100237. PubMed ID: 33102135
[TBL] [Abstract][Full Text] [Related]
18. Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study.
Roussel R; Riveline JP; Vicaut E; de Pouvourville G; Detournay B; Emery C; Levrat-Guillen F; Guerci B
Diabetes Care; 2021 Jun; 44(6):1368-1376. PubMed ID: 33879536
[TBL] [Abstract][Full Text] [Related]
19. Flash Glucose Measurements in Children with Type 1 Diabetes in Real-Life Settings: To Trust or Not to Trust?
Szadkowska A; Gawrecki A; Michalak A; Zozulińska-Ziółkiewicz D; Fendler W; Młynarski W
Diabetes Technol Ther; 2018 Jan; 20(1):17-24. PubMed ID: 29235898
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
